Supplement evidence
L-Theanine
Nine small trials, none in a diagnosed anxiety disorder, and one null pooled estimate.
page first published · last updated
What Its Legal Status Actually Means
Read this before anything below it. Legal to sell is not the same fact as reviewed, verified, or approved.
L-theanine is sold in the US as a dietary supplement under the Dietary Supplement Health and Education Act of 1994 (DSHEA), and as a food additive it holds Generally Recognized as Safe (GRAS) status for use in beverages. Neither of those is an efficacy approval: the FDA does not review L-theanine supplements for effectiveness before sale, does not verify that a capsule contains the dose on the label, and has never approved L-theanine to prevent or treat anxiety, stress, insomnia, or any other condition. Branded forms used in research (Suntheanine from Taiyo Kagaku, AlphaWave from Ethical Naturals) are proprietary preparations sold by the same companies that funded the trials testing them.
Quoted whole from the 2026-08-18 study harvest. Not summarized, not shortened.
does l-theanine work for anxiety and stress? what the trials say
there is no fda label for l-theanine, because it is sold as a dietary supplement and has never been reviewed for effectiveness. the regulatory facts below come from the legal-status paragraph above, written from the regulator’s documents in the 2026-08-18 study harvest; every trial figure is from a study record on this page. every source is linked at the end of this section. last checked 2026-10-05.
l-theanine is the amino acid in tea that is sold in capsules for stress, anxiety and sleep. it is one of the most-searched supplements on this site, and the whole human evidence base for it is nine small randomised trials, none in anyone with a diagnosed anxiety disorder. this section says what its legal status means, what the trials measured and in whom, what they found in both directions, who paid for them, and what the one pooled estimate shows. every number is from a study record on this page, and each source is linked at the end.
this is information to take to a prescriber or pharmacist. nothing here tells anyone to take l-theanine or to stop, and nothing here is a reason to put off treatment that works.
what its legal status means, and does not mean
l-theanine is sold in the united states as a dietary supplement under the 1994 dietary supplement health and education act, and as a food additive it holds "generally recognized as safe" status for use in beverages [status]. neither is an approval of effectiveness. the fda does not review l-theanine supplements for effectiveness before sale, does not verify that a capsule contains the dose on its label, and has never approved l-theanine to prevent or treat anxiety, stress, insomnia or any other condition [status]. legal to sell is not the same fact as reviewed, verified or approved.
one more fact about the supply chain belongs here: the branded forms used in the research, suntheanine (taiyo kagaku) and alphawave (ethical naturals), are proprietary preparations sold by the same companies that funded the trials testing them [status]. that matters when reading the trials below.
what the trials measured, in whom, and for how long
a 2020 systematic review found only nine peer-reviewed randomised controlled trials of pure supplemental l-theanine against a control for stress or anxiety in humans [williams-2020]. the trials are small, 16 to 34 people in the ones on this page; short, from a single dose to four weeks; and almost entirely in healthy or mildly stressed volunteers rather than anyone with a diagnosis [risks]. no trial in people with a diagnosed anxiety disorder was found in pubmed, and that absence is the story [exclusions].
what they measured also matters. two of the trials on this page measured brain-wave (alpha) power and salivary cortisol one to three hours after a single dose during a laboratory stress task [evans-2021; white-2016]. those are mechanism readouts, not clinical outcomes. one trial measured depression, anxiety and sleep questionnaires after four weeks in 30 healthy adults [hidese-2019]. that is the closest thing to a treatment study, and it was in people with nothing to treat.
what the research says, in both directions
in favour. in 30 healthy adults with no major psychiatric illness, 200 mg a day for four weeks, against placebo in a crossover design, lowered depression, trait anxiety and sleep-quality scores (p = 0.019, 0.006 and 0.013) and improved verbal fluency [hidese-2019]. in 34 healthy adults aged 18 to 40, an l-theanine-based drink before a multitasking stressor lowered self-reported stress at one hour and the cortisol response at three hours, with no change in cognitive performance [white-2016]. in 16 moderately stressed adults, a single 200 mg dose raised alpha brain-wave power at three hours and lowered cortisol at one hour [evans-2021]. the 2020 review concluded that 200 to 400 mg a day "may assist" in reducing stress and anxiety in people exposed to stressful conditions [williams-2020].
against, or smaller than the badge suggests. the only pooled quantitative estimate of l-theanine for anxiety is null: in a bayesian network meta-analysis of 29 randomised trials of 12 medicinal herbs in adults with diagnosed or subthreshold anxiety, l-theanine moved the hamilton anxiety scale by −0.49 points with a 95% credible interval from −6.54 to 5.57, which straddles zero in both directions [zhang-2022]. the review that said "may assist" did not pool the trials or grade the certainty of the evidence, and said plainly that longer and larger studies are needed before l-theanine can be clinically justified as a therapeutic agent [williams-2020]. a null across a wide interval means "not proven to work", not "proven not to work": the l-theanine arm rests on few small trials, so a modest real effect cannot be ruled out [zhang-2022].
who paid. the 30-person trial was funded by taiyo kagaku, which makes suntheanine; two of its seven authors are company employees and the company supplied both the active and placebo tablets, and several outcomes were measured before-and-after within person rather than against placebo, which inflates apparent effects [hidese-2019]. the 16-person trial and the journal’s rapid-service fee were funded by ethical naturals, which sells the alphawave product tested, and the trial ran at a contract research organisation [evans-2021]. the 34-person drink trial was funded by a beverage company with a commercial interest in the drink, and the drink had several ingredients, so the effect cannot be attributed to l-theanine alone [white-2016]. the null network meta-analysis came from a traditional chinese medicine research institute, which if anything would lean toward finding herbal benefits, making its null for l-theanine harder to dismiss [zhang-2022].
the risks the harvest recorded
l-theanine looks benign. trials at 200 to 400 mg a day for up to four weeks report no adverse events beyond placebo, and the amino acid occurs naturally in tea, so most people have consumed small amounts for years [risks]. the honest problem is not safety; it is that the evidence is thin to the point of being uninformative [risks].
two practical cautions. because l-theanine is mildly sedating in some people, combining it with alcohol, sedatives or blood-pressure medication has not been studied, and that is a reasonable thing to ask a pharmacist about [risks]. and nothing here establishes that it treats an anxiety disorder, so the real risk is substitution: using it instead of treatment that does [risks].
questions for a prescriber or pharmacist about l-theanine
each one comes from a warning or a study above. they are questions, not instructions; the answers depend on a history nobody here has.
- the one pooled analysis found l-theanine no better than placebo for anxiety. if i am spending money on it monthly, is there something with actual evidence i should try alongside or instead?
- the whole literature is nine small trials in stressed volunteers, none with a diagnosis. how much weight would you put on it for someone in my situation?
- the trials used 200 to 400 mg a day, and the fda does not check that a capsule contains what the label says. does the product i am looking at state its dose and a third-party test?
- i take alcohol, a sedative or a blood-pressure medication. the combination has not been studied; what would you want to know before i add it?
- the four-week trial was funded by the maker and most outcomes were measured before-and-after rather than against placebo. does that change how you read it?
- if i feel calmer on it, how would we tell the amino acid from the expectation, and what would an actual benefit have to look like?
questions people ask
- does l-theanine work for anxiety?
- not shown. the only pooled estimate, a 2022 network meta-analysis of 29 trials of medicinal herbs in adults with diagnosed or subthreshold anxiety, found l-theanine no better than placebo on the hamilton anxiety scale (−0.49 points, credible interval −6.54 to 5.57). small trials in healthy or stressed volunteers report lower stress scores and cortisol after a dose, and a 2020 review of the nine trials that exist said it "may assist" while calling for larger and longer studies. no trial has been run in people with a diagnosed anxiety disorder.
- is l-theanine fda approved?
- no. it is sold as a dietary supplement under the 1994 dietary supplement health and education act and holds "generally recognized as safe" status as a food additive in beverages. neither is an approval of effectiveness: the fda does not review l-theanine supplements for effectiveness before sale, does not verify that a capsule contains the labelled dose, and has never approved it to prevent or treat any condition.
- what did the 2019 l-theanine trial in healthy adults find?
- the study searchers most often land on here (hidese and colleagues, nutrients 2019) gave 30 healthy adults with no major psychiatric illness 200 mg a day of l-theanine or placebo for four weeks each in a crossover design. depression, trait anxiety and sleep-quality scores fell after the l-theanine period and verbal fluency improved. it was funded by taiyo kagaku, which makes the suntheanine brand tested, two authors were company employees, and with 30 people and no diagnosed condition it suggests a direction rather than establishing that l-theanine treats anything.
- how much l-theanine did the studies use, and is it safe?
- the trials used 200 to 400 mg a day, or a single 200 mg dose, for up to four weeks, and reported no adverse events beyond placebo at those doses. it is mildly sedating in some people, and its combination with alcohol, sedatives or blood-pressure medication has not been studied. nothing is known about longer use at supplement doses, because no trial ran longer than four weeks.
- can l-theanine replace anxiety treatment?
- nothing in the evidence supports that. no trial has tested it in people with an anxiety disorder, the one pooled estimate is null, and the harvest that built this page names substitution, using it instead of treatment that works, as the most likely harm. it is a question for a prescriber, not a web page.
sources for this section
the library rows link to our one-page summary of each study, with the original paper, its funding and our evidence grade on that page.
- the legal-status paragraph on this page (dshea; gras for beverages; no efficacy review; branded forms and their funders), written from the regulator’s documents in the 2026-08-18 study harvest and quoted whole above
- the risks paragraph on this page (the 2026-08-18 study harvest’s known-risks record for l-theanine)
- the "what is not known" notes on this page: no trial in a diagnosed anxiety disorder found in pubmed; no meta-analysis of l-theanine alone exists; whole-tea trials excluded
- zhang w, et al. medicinal herbs for the treatment of anxiety: a systematic review and network meta-analysis. pharmacological research 2022 (independently funded) (library row)
- williams jl, et al. the effects of green tea amino acid l-theanine consumption on the ability to manage stress and anxiety levels: a systematic review. plant foods for human nutrition 2020 (library row)
- hidese s, et al. effects of l-theanine administration on stress-related symptoms and cognitive functions in healthy adults: a randomized controlled trial. nutrients 2019 (industry funded: taiyo kagaku) (library row)
- white dj, et al. anti-stress, behavioural and magnetoencephalography effects of an l-theanine-based nutrient drink: a randomised, double-blind, placebo-controlled, crossover trial. nutrients 2016 (industry funded: neurobrands) (library row)
- evans m, et al. a randomized, triple-blind, placebo-controlled, crossover study to investigate the efficacy of a single dose of alphawave l-theanine on stress in a healthy adult population. neurology and therapy 2021 (industry funded: ethical naturals) (library row)
What the Research Shows
5 records from the 2026-08-18 harvest, each checked against PubMed and Europe PMC on that date. How a study was designed, how many people were in it, and who paid for it are printed above what it found, because those three facts decide how much the finding is worth.
Study 1 · 2022
- Meta-analysis of randomized trials
- Reputable journal
- Independently funded
strong80/100Well-supported by good-quality research.
Read this first: A null result across a wide credible interval means "not proven to work", not "proven not to work" — the L-theanine arm of this network rests on few small trials, so a modest real effect cannot be ruled out. The analysis came from a traditional Chinese medicine research institute, which if anything would bias it toward finding herbal benefits, making the null finding for L-theanine harder to dismiss.
In a Bayesian network meta-analysis of 29 randomized trials of 12 medicinal herbs in adults with diagnosed or subthreshold anxiety, L-theanine did not beat placebo: the effect on the Hamilton Anxiety Scale was -0.49 points with a 95% credible interval of -6.54 to 5.57, which straddles zero in both directions. This is the only pooled quantitative estimate of L-theanine for anxiety found in the literature, and it is null.
How this record was checked
PubMed record 35378276 fetched via NCBI efetch 2026-08-18; title, authors, journal, year, DOI, the 29-trial count, and the L-theanine estimate (MD -0.49, 95% CrI -6.54 to 5.57) confirmed verbatim from the abstract. Europe PMC core record fetched 2026-08-18 lists funders "Beijing University of Chinese Medicine" and "National Major Science and Technology Projects of China" and no commercial sponsor, hence funding INDEPENDENT.
Study 2 · 2020
- Systematic review of randomized trials
- Reputable journal
- Funding not established
moderate62/100Reasonable evidence with real limitations.
Read this first: The review did not pool the trials or grade certainty of evidence, so "may assist" is a narrative judgement rather than a measured effect; none of the nine trials studied people with a diagnosed anxiety disorder, and several were manufacturer-funded.
A PRISMA-guided systematic review found only nine peer-reviewed randomized controlled trials of pure supplemental L-theanine against a control for stress or anxiety in humans. The authors concluded 200-400 mg per day "may assist" in reducing stress and anxiety in people exposed to stressful conditions, while stating plainly that longer-term and larger-cohort studies are needed before L-theanine can be clinically justified as a therapeutic agent. Nine small trials is the entire evidence base.
How this record was checked
PubMed record 31758301 fetched via NCBI efetch 2026-08-18; title, authors, journal, year, DOI, the nine included articles, and the 200-400 mg/day figure confirmed verbatim from the abstract. Europe PMC core record fetched 2026-08-18 returned no grant or funding list and the Springer article page was not retrievable, so funding is recorded UNKNOWN rather than inferred.
Study 3 · 2019
- Randomized trial
- 30 participants
- Indexed journal
- Industry funded
- Declared conflicts of interest
early signal44/100Suggestive but preliminary. Not settled.
Read this first: Funded by Taiyo Kagaku Co., Ltd., which manufactures the Suntheanine-brand L-theanine; two of the seven authors are employees of that company and it supplied both the active and placebo tablets. Several outcomes were measured within-person before-and-after rather than against placebo, which inflates apparent effects.
Thirty healthy adults with no major psychiatric illness took 200 mg/day of L-theanine or placebo for four weeks each in a crossover design. Depression, trait anxiety, and sleep quality scores all fell after the L-theanine period (p=0.019, 0.006, and 0.013), and verbal fluency improved. With 30 participants, a four-week exposure, and no diagnosed condition among them, this trial can suggest a direction but cannot establish that L-theanine treats anything.
How this record was checked
PubMed record 31623400 fetched via NCBI efetch 2026-08-18; title, authors, journal, year, DOI, N=30, the 200 mg/day dose, the four-week crossover design, and the p-values confirmed verbatim from the abstract, and the conflict statement naming Taiyo Kagaku employment read directly off the record. Europe PMC core record fetched 2026-08-18 lists the funder as "Funding received from Taiyo Kagaku Co., Ltd., Mie, Japan", hence funding INDUSTRY and independent false.
Study 4 · 2016
- Randomized trial
- 34 participants
- Indexed journal
- Industry funded
- Declared conflicts of interest
early signal44/100Suggestive but preliminary. Not settled.
Read this first: "The study was funded by a grant from Neurobrands CA, USA", a beverage company with a commercial interest in the L-theanine drink tested; the authors state the funder had no input into design, conduct, or interpretation. The tested product was a multi-ingredient drink, not isolated L-theanine, so the effects cannot be attributed to L-theanine alone.
Thirty-four healthy adults aged 18-40 drank an L-theanine-based nutrient drink or placebo before a multitasking cognitive stressor. Self-reported stress one hour after dosing was lower on the active drink, and the salivary cortisol response was lower three hours after dosing; no cognitive performance changes were seen at all, and the brain-wave (alpha) changes appeared only in participants higher in trait anxiety and did not correlate with either the stress or cortisol results. This is a single-dose laboratory stress test in healthy volunteers, not a treatment study.
How this record was checked
PubMed record 26797633 fetched via NCBI efetch 2026-08-18; title, authors, journal, year, DOI, N=34, and the pattern of results (subjective stress at 1 h, cortisol at 3 h, no cognitive change, alpha effects only in high-trait-anxiety participants) confirmed verbatim from the abstract. Europe PMC full text (PMC4728665) retrieved 2026-08-18: the Conflicts of Interest section reads "The study was funded by a grant from Neurobrands CA, USA", hence funding INDUSTRY and independent false.
Study 5 · 2021
- Randomized trial
- 16 participants
- Indexed journal
- Industry funded
- Preregistered
- Declared conflicts of interest
early signal48/100Suggestive but preliminary. Not settled.
Read this first: "This study and the journal's Rapid Service Fee was funded by Ethical Naturals Inc., California, USA", the company that sells the AlphaWave L-theanine tested; the trial was run at a contract research organisation. With 16 participants and one participant lost after period 1, the trial is far too small to support the conclusion in its own discussion that the product "should be considered as a nutraceutical supplement to manage acute stress."
Sixteen moderately stressed healthy adults received a single 200 mg dose of branded L-theanine or placebo before a mental-arithmetic stress task. Frontal and whole-scalp alpha brain-wave power was higher three hours after the active dose and salivary cortisol fell more one hour after it. Sixteen people, one dose, and brain-wave and hormone readouts rather than any clinical outcome — this is a mechanism demonstration, not evidence that L-theanine reduces anxiety in daily life.
How this record was checked
PubMed record 34562208 fetched via NCBI efetch 2026-08-18; title, authors, journal, year, DOI, the single 200 mg dose, the triple-blind crossover design, and ClinicalTrials.gov registration NCT04706494 confirmed verbatim from the abstract. Europe PMC full text (PMC8475422) retrieved 2026-08-18: the Results section states "16 eligible participants were enrolled and randomized" (8 per sequence), and the Funding section reads "This study and the journal's Rapid Service Fee was funded by Ethical Naturals Inc., California, USA", hence N=16, funding INDUSTRY, and independent false. Europe PMC core record additionally lists the grant agency as "Ethical Naturals Inc."
The Risks
Nobody checks this purchase the way a prescription is checked. No prescriber reviews it against the rest of what you take, no pharmacist screens the interaction, and no regulator confirms the dose in the capsule before it is sold. That is why this section sits here at full length rather than as a footnote.
What the paragraph below covers:
- Drug interactions
- Sedation
L-theanine looks benign. Trials at 200-400 mg per day for up to four weeks report no adverse events beyond placebo, and the amino acid occurs naturally in tea, so most people have been consuming small amounts for years. The honest problem is not safety, it is that the evidence is thin to the point of being uninformative: the trials are tiny (16 to 34 people), short (single dose to four weeks), almost entirely in healthy or mildly stressed volunteers rather than anyone with a diagnosis, and predominantly paid for by the companies selling the ingredient. The one pooled quantitative estimate available found L-theanine no better than placebo for anxiety. Because it is mildly sedating in some people, combining it with alcohol, sedatives, or blood-pressure medication has not been studied and is a reasonable thing to ask a pharmacist about. Nothing here establishes that it treats an anxiety disorder, and nobody should substitute it for treatment that does.
What Is Not Known
The boundaries of the section above, in the harvest’s own words. What it excluded, why, and where it looked and found nothing. An absence of evidence is not evidence of absence, and it is not evidence of benefit either.
What Was Left Out, and Why
Quoted from the harvest, where these notes sat above the study list rather than after it. Where a note says “below” it means the studies in the section above.
- Green-tea and matcha beverage trials (e.g. Unno 2018 PMID 30308973, Unno 2017 PMID 28566632) excluded: they test whole tea, where caffeine and catechins confound the theanine signal, and cannot tell a reader what a 200 mg L-theanine capsule does.
- No trial of L-theanine in people with a diagnosed anxiety disorder was found in PubMed. That absence is the story: every entry below studies healthy or self-reported-stressed volunteers.
- No meta-analysis of L-theanine alone exists; the network meta-analysis below is the only pooled quantitative estimate found, and it is null.
The Retraction Check
PubMed efetch records for all five PMIDs inspected 2026-08-18 for "Retraction in", "Expression of concern", "Erratum in", and "Withdrawn" flags; none present.
Questions for a Prescriber or Pharmacist
This page does not tell anyone to take L-Theanine or to avoid it. It is not able to: it does not know what else you take, what you have tried, or what you are treating. These are the questions each study above raises, written to be asked out loud.
- The one pooled analysis of L-theanine for anxiety found it no better than placebo — if I'm spending money on it monthly, is there something with actual evidence I should try instead?
- The whole L-theanine literature is nine small trials in stressed volunteers — is that enough for you to recommend it, or is it something to try only alongside proper treatment?
- This 30-person trial was funded by the company that makes the L-theanine and ran for four weeks in people with no diagnosis — how much weight would you put on it for someone in my situation?
- This kind of study measures how someone feels an hour after a dose during a lab stress task — does that tell us anything useful about whether it would help my day-to-day anxiety?
- Studies like this measure brain waves and cortisol after one dose in 16 people — what would an actual clinical benefit have to look like before you'd suggest I use this?
And the one to ask at the counter, whatever the answers above turn out to be: given everything I am already taking, what would you want to know about L-Theanine before I put it in the same body?
Open L-Theanine in veisund
The app has the resources behind this page and people working through the same questions.What you post there goes to people, not to a model. If someone answers, it is a person who has been there. The one automated message is a crisis-resource reply.
Where This Page Comes From
Transcribed from the study-harvest-2026-08-18 record for l-theanine, built into this page by scripts/supplement-ingest.mjs on 2026-09-07. Nothing here is fetched at page load, and nothing here was written by a model without a citation behind it.
| Source file | study-harvest/2026-08-18/l-theanine.yaml |
|---|---|
| Source repo | REPTechnologies/avalo-backend |
| SHA-256 | 6a620611fdb5df95bae488ce741b4b7ca492367fdefcb1526780cab83387b642 |
| Also searched as | L-theanine, theanine, Suntheanine, AlphaWave, gamma-glutamylethylamide, green tea amino acid |
The Other Substances
- 5-HTP
- Ashwagandha
- Cannabidiol (CBD)
- Cannabis and THC
- Creatine
- Kratom
- Magnesium
- Melatonin
- Methylene Blue
- Microdosing
- N-Acetylcysteine (NAC)
- Omega-3
- Phenibut
- SAMe
- St John’s Wort
- Valerian
Do any supplements actually work? asks the question across all of them. The full library has the medication records, the funding investigations, and the glossary.
